SCHEMBL30984005

SCHEMBL30984005

COC(=O)c1ccc(-c2nc3c(OC4(C)CC4)ncnc3n2Cc2ccccc2)c(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 2/20 0.40
▸ OPRK1 P41145 1/20 0.38
▸ PIK3CD O00329 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ KCNH2 Q12809 1/20 0.36
▸ GRM2 Q14416 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ TBXA2R P21731 1/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ CNR1 P21554 2/20 0.35
▸ CNR2 P34972 2/20 0.35
▸ DCTPP1 Q9H773 1/20 0.35
▸ YTHDC1 Q96MU7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983906 0.93 PIK3CD (0.39) PIK3CDMEN1KMT2APDE10ACNR1
SCHEMBL31321968 0.91 MAPK14 (0.40) PIK3CDPDE10ACNR1CNR2YTHDC1
SCHEMBL31321972 0.91 PIK3CD (0.38) CFTROPRK1PIK3CDKCNH2PDE10A
SCHEMBL30983480 0.89 F2 (0.39) PIK3CDALDH1A1PDE10ACNR1CNR2
SCHEMBL31268855 0.87 CNR1 (0.38) PIK3CDCNR1
SCHEMBL30983776 0.86 PIK3CD (0.40) PIK3CDMEN1KMT2APDE10ACNR1
SCHEMBL30983817 0.85 CNR1 (0.41) PIK3CDALDH1A1KMT2APDE10ACNR1
SCHEMBL30983826 0.85 PIK3CD (0.39) PIK3CDMEN1KMT2APDE10ACNR1
SCHEMBL31269290 0.85 PIK3CD (0.37) PIK3CDPDE10ACNR1CNR2
SCHEMBL30983784 0.85 PIK3CD (0.40) PIK3CDMEN1KMT2APDE10ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback